Breast cancer

Trial Evaluating Role of Post Mastectomy Radiotherapy in Women With Node Negative Early Breast Cancer

Who can joinWomen

Age18–80 years

Kind of studyStudy of how care is given

What it testsRadiation

The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.

Where to go

2 hospitals in India taking patients for this trial.

Post Graduate Institute of Medical Education & ResearchChandigarh, ChandigarhDirections ↗

Tata Memorial CentreMumbai, MaharashtraDirections ↗

Registry summary (technical)

Postmastectomy radiotherapy (PMRT) is unequivocally beneficial in reducing the recurrences as well as improving survival in node positive breast cancer patients. PMRT for women with T1-T2 tumors and negative axillary nodes is not generally warranted because of the presumed low risk of recurrence in this population as a whole. However, in the setting of multiple adverse prognostic factors, the recurrence risk approaches and in some cases surpasses the risk of recurrence documented for patients with one to three positive lymph nodes. Numerous retrospective series have reported the outcome and pa…

Sponsor: Tata Memorial Centre
NCT02992574 on ClinicalTrials.gov · CTRI number CTRI/2016/12/007532
Last updated on the registry 10 Apr 2025 · read by us 20 Oct 2026

Breast cancer

Where to go

Need help reaching the trial team? Write to us.